Skip to main content
. 2007 Apr 10;64(3):266–277. doi: 10.1111/j.1365-2125.2007.02887.x

Figure 1.

Figure 1

The model for the mechanistic pathway of drug response consists of: a pharmacokinetic (PK) model for the dose–exposure relationship, a pharmacokinetic biomarker model for the exposure–biomarker relationship and biomarker clinical end-point model for the biomarker–clinical end-point relationship and a pharmacokinetic toxicity (Tox) model for the exposure–toxicity relationship.